Get the Stockscreener App
1.41
4.08%
-0.06
Anebulo Pharmaceuticals Inc Stock (ANEB) Forecast
The Anebulo Pharmaceuticals Inc (ANEB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.029, representing a -27.02% decrease from the current price of $1.41. The highest analyst price target is $2.0382, and the lowest is $0.0197.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ANEB Price Target
Average 1.0249
(-27.31% Downside)
Is Anebulo Pharmaceuticals Inc (ANEB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 72.65 | Sell |
| STOCH(9,6) | 82.42 | Sell |
| STOCHRSI(14) | 81.25 | Sell |
| MACD(12,26) | 0.1029 | Buy |
| ADX(14) | 40.14 | Buy |
| William %R | -15.13 | Sell |
| CCI(14) | 171.41 | Buy |
Buy: 3
Sell: 4
Neutral: 0
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.2852
Buy
|
1.3435
Buy
|
| MA20 |
1.1848
Buy
|
1.2391
Buy
|
| MA50 |
1.0992
Buy
|
1.1871
Buy
|
| MA100 |
1.2469
Buy
|
1.2657
Buy
|
| MA200 |
1.4833
Buy
|
1.5223
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ANEB could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 4 signaling Sell signals and 0 Neutral signals. This might be a good time to open fresh positions on ANEB, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 72.65 indicates that ANEB is overbought. This suggests that ANEB price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 82.42 indicates that ANEB is oversold. This means that ANEB price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 81.25 indicates that ANEB is oversold. This suggests that ANEB price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 40.14 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 171.41 indicates that ANEB is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term ANEB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Anebulo Pharmaceuticals Inc financial reports and earnings history, Anebulo Pharmaceuticals Inc (ANEB) stock could reach $1.9418 by 2030, $16.92 by 2040 and $25.98 by 2050. See the projected annual prices until 2050 of the Anebulo Pharmaceuticals Inc stock below:
- Anebulo Pharmaceuticals Inc (ANEB) is expected to reach an average price of $9.4353 in 2035, with a high prediction of $9.0871 and a low estimate of $8.8882. This indicates an $569.17% rise from the last recorded price of $1.41.
- Anebulo Pharmaceuticals Inc (ANEB) stock is projected to chart a bullish course in 2040, with an average price target of $17.13, representing an $1,115% surge from its current level. The forecast ranges from a conservative $5.6577 to a sky-high $16.92.
- Our analysts predict Anebulo Pharmaceuticals Inc (ANEB) to jump 1,022% by 2045, soaring from $15.91 to an average price of $15.82, potentially reaching $15.76. While $15.91 is the low estimate, the potential upside is significant.
- Anebulo Pharmaceuticals Inc (ANEB) stock is expected to climb by 2050, reaching an average of $25.66, a $1,720% jump from its current level. However, a wide range of estimates exists, with high and low targets of $25.98 and $25.66, respectively, highlighting the market's uncertainty.
Anebulo Pharmaceuticals Inc Stock (ANEB) Year by Year Forecast
Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2025
Anebulo Pharmaceuticals Inc Stock (ANEB) is expected to reach an average price of $2.1947 in 2025, with a high prediction of $4.3697 and a low estimate of $0.0197. This indicates an +55.65% rise from the last recorded price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $0.0647 | $0.0197 | $2.0382 | -95.41% |
| August, 2025 | $0.2588 | $0.1088 | $0.8988 | -81.64% |
| September, 2025 | $0.5024 | $0.0947 | $0.5847 | -64.37% |
| October, 2025 | $0.4619 | $0.3642 | $0.4213 | -67.24% |
| November, 2025 | $0.5154 | $0.2895 | $0.6046 | -63.45% |
| December, 2025 | $0.1951 | $0.2049 | $0.6109 | -86.16% |
Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2026
The predicted value for Anebulo Pharmaceuticals Inc (ANEB) in 2026 is set at an average of $0.9035. Estimates vary from a peak of $1.7953 to a trough of $0.0117, indicating an -35.92% surge from the present price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.3129 | $0.0316 | $0.6092 | -77.81% |
| February, 2026 | $0.028 | $0.028 | $0.3939 | -98.02% |
| March, 2026 | $0.2644 | $0.0117 | $0.6721 | -81.25% |
| April, 2026 | $0.1349 | $0.0126 | $0.5685 | -90.43% |
| May, 2026 | $0.2486 | $0.2486 | $0.2678 | -82.37% |
| June, 2026 | $0.2719 | $0.1903 | $0.3196 | -80.72% |
| July, 2026 | $0.1872 | $0.1057 | $0.1492 | -86.72% |
| August, 2026 | $0.4748 | $0.1434 | $1.0347 | -66.33% |
| September, 2026 | $0.9453 | $0.213 | $1.7953 | -32.95% |
| October, 2026 | $0.2619 | $0.0482 | $1.4695 | -81.43% |
| November, 2026 | $0.1018 | $0.0401 | $0.7859 | -92.78% |
| December, 2026 | $0.2988 | $0.0454 | $0.4764 | -78.81% |
Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Anebulo Pharmaceuticals Inc (ANEB) is $0.796, with a high forecast of $1.5391 and a low forecast of $0.0529. This indicates an -43.55% decrease from the last price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.4052 | $0.0529 | $0.816 | -71.26% |
| February, 2027 | $0.4666 | $0.2993 | $0.5865 | -66.91% |
| March, 2027 | $0.9622 | $0.5057 | $1.3981 | -31.76% |
| April, 2027 | $0.7086 | $0.5886 | $1.4045 | -49.75% |
| May, 2027 | $1.13 | $0.5827 | $1.3509 | -19.86% |
| June, 2027 | $1.0582 | $0.8632 | $1.5391 | -24.95% |
| July, 2027 | $1.1735 | $1.0017 | $1.0235 | -16.77% |
| August, 2027 | $1.2607 | $1.1089 | $0.7671 | -10.59% |
| September, 2027 | $0.9796 | $0.8778 | $0.9958 | -30.53% |
| October, 2027 | $1.2866 | $1.0021 | $0.8967 | -8.75% |
| November, 2027 | $0.8438 | $1.2621 | $0.8685 | -40.15% |
| December, 2027 | $0.3028 | $0.5558 | $0.7156 | -78.53% |
Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2028
In 2028, Anebulo Pharmaceuticals Inc (ANEB) is projected to reach an average price of $1.9226, with a high projection of $3.662 and a low estimate of $0.1832. This indicates an +36.36% rise from the last price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.4999 | $0.3981 | $0.6669 | -64.55% |
| February, 2028 | $0.357 | $0.427 | $0.673 | -74.68% |
| March, 2028 | $0.2041 | $0.1832 | $0.8594 | -85.53% |
| April, 2028 | $3.1131 | $0.5977 | $2.3231 | +120.79% |
| May, 2028 | $3.982 | $3.0101 | $3.662 | +182.41% |
| June, 2028 | $1.5791 | $3.7991 | $3.3838 | +12.00% |
| July, 2028 | $3.3563 | $1.5994 | $1.8462 | +138.03% |
| August, 2028 | $2.8152 | $2.5934 | $3.2098 | +99.66% |
| September, 2028 | $2.3523 | $2.9923 | $2.8565 | +66.83% |
| October, 2028 | $3.0694 | $2.7141 | $2.9076 | +117.69% |
| November, 2028 | $3.1984 | $3.3384 | $3.4748 | +126.83% |
| December, 2028 | $3.6355 | $3.4683 | $3.4055 | +157.84% |
Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2029
The 2029 price forecast for Anebulo Pharmaceuticals Inc Stock (ANEB) is $2.1936 on average, with a high prediction of $3.1562 and a low estimate of $1.2311. This represents an +55.58% increase from the previous price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.2707 | $3.1791 | $2.8973 | +131.97% |
| February, 2029 | $2.9214 | $3.0098 | $3.1562 | +107.19% |
| March, 2029 | $2.5537 | $2.6787 | $2.8333 | +81.11% |
| April, 2029 | $2.5559 | $2.5401 | $2.3905 | +81.27% |
| May, 2029 | $2.4246 | $2.5628 | $2.4794 | +71.96% |
| June, 2029 | $2.7769 | $2.4065 | $2.7769 | +96.94% |
| July, 2029 | $2.479 | $2.699 | $2.7037 | +75.82% |
| August, 2029 | $2.4568 | $2.5639 | $2.5543 | +74.24% |
| September, 2029 | $2.575 | $2.5015 | $2.575 | +82.63% |
| October, 2029 | $1.804 | $1.8522 | $1.654 | +27.94% |
| November, 2029 | $1.2011 | $1.2311 | $1.9057 | -14.82% |
| December, 2029 | $1.6882 | $1.4529 | $1.3982 | +19.73% |
Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2030
Anebulo Pharmaceuticals Inc Stock (ANEB) is expected to reach an average price of $2.7437 in 2030, with a high forecast of $4.9853 and a low forecast of $0.5021. This signifies an +94.59% surge from the last price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.0671 | $2.1299 | $1.9418 | +46.61% |
| February, 2030 | $1.7843 | $1.9575 | $1.859 | +26.54% |
| March, 2030 | $1.6014 | $1.6296 | $1.7561 | +13.58% |
| April, 2030 | $1.3135 | $1.4385 | $1.4668 | -6.84% |
| May, 2030 | $1.0275 | $0.9257 | $1.1603 | -27.13% |
| June, 2030 | $1.1346 | $0.9692 | $1.1146 | -19.53% |
| July, 2030 | $0.7899 | $0.7717 | $0.6991 | -43.98% |
| August, 2030 | $4.9443 | $0.5021 | $4.9443 | +250.66% |
| September, 2030 | $4.9457 | $4.9776 | $4.9853 | +250.76% |
| October, 2030 | $5.0513 | $4.8871 | $4.8871 | +258.25% |
| November, 2030 | $4.482 | $4.7267 | $4.362 | +217.88% |
| December, 2030 | $5.2927 | $4.9774 | $4.6751 | +275.37% |
1.37%
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):